Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B.C. Cho
P1.16-06 Expanded Efficacy and Safety Analysis of PACIFIC Based on a PD-L1 Cutpoint of 25%
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA10.06 a First-In-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
‹
1
2
Related publications
FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.16-03 Prognostic Significance of PD-L1 in Stage II/III Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Efficacy and Potential Predictive Factors of PD-1/PD-L1 Blockades in Epithelial Carcinoma Patients: A Systematic Review and Meta Analysis
Oncotarget
Oncology
The Efficacy and Safety of Combination of PD-1 and CTLA-4 Inhibitors: A Meta-Analysis
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
The Efficacy and Safety of Anti-Pd-1/Pd-L1 Antibodies Combined With Chemotherapy or CTLA4 Antibody as a First-Line Treatment for Advanced Lung Cancer
International Journal of Cancer
Cancer Research
Oncology
The Safety and Tolerability of Combined Immune Checkpoint Inhibitors (Anti-Pd-1/Pd-L1 Plus Anti-Ctla-4): A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Erratum: The Efficacy and Safety of Anti‐PD‐1/Pd‐l1 Antibodies Combined With Chemotherapy or CTLA4 Antibody as a First‐line Treatment for Advanced Lung Cancer
International Journal of Cancer
Cancer Research
Oncology
Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment
Clinical and Experimental Immunology
Allergy
Immunology
Comprehensive Analysis of PD-L1 Expression in Glioblastoma Multiforme
Oncotarget
Oncology
